Nasal Delivery

Nasal drug delivery has been in use for many years, primarily for the delivery of small molecules for use in respiratory and allergic rhinitis. Nasal drug delivery offers an alternative route of administration over injection.

Solutions for Nasal Delivery:

METHOCEL™ Cellulose Ethers have unique capabilities to control solution viscosity, direct drug spray pattern and retain drug on the mucosa to allow for permeation. These are key requirements for the deposition and delivery of small molecules & biologics.

POLYOX™ resins offers a number of important properties for mucoadhesion, including water solubility, hydrophilicity, high molecular weight, hydrogen bonding functionality, and good biocompatibility. Their long linear chain structure helps them to form a strong interpenetrating network with mucus. The polymer can be used in nasal solution applications.

 
 
 

Related Applications

Thumb_Excipients_AbuseDeterrence.jpg

Dow’s excipients for drug abuse deterrence applications provide tamper resistant properties.

Thumb_Excipients_APIStability.jpg

Dow offers solutions to protect APIs from environmental conditions and increase the stability of a drug’s long-term quality, efficacy and safety

yellow_capsules_shutterstock_56239201_3_Card_Layout.png

Utilizing a novel patented process (alginate) this technology provides a unique seamless, enteric, vegetarian alternative to gelatin soft capsules in one unit process for pharmaceutical and nutraceutical applications.

mother_and_daughter_shutterstock_15995386_3Card_Layout.png

Alginate-based impressions are attractive as orthodontic study models for a variety of reasons. These are fast setting at room temperature, easy to prepare, and very cost effective.

4.2.9_Thumb_enteric_coating.jpg

Dow’s excipients for the enteric coating of pharmaceutical tablets.

shutterstock_562215688_3_cart_Layout.png

An enteric coating resists disintegration in the low pH of the stomach and is dissolved in the neutral pH environment of the intestine

iStock-179133772.png

Suspensions are pharmaceutically stable dispersions of an insoluble or sparingly-soluble drug in a liquid vehicle, usually an aqueous solution. They can be ready-to-use or reconstitutable, where the drug is mixed with other ingredients in the dry state and reconstituted with water at the time of dispensing to the patient.

shutterstock_564214432_3_cart_Layout.png

Use of Avicel® DG dramatically increases tablet hardness, improves yields and provides good flow and a robust ribbon during the initial compaction phase

shutterstock_373422979_3_cart_Layout.png

Dow’s excipients for controlled or modified release tablet and capsule formulations.

iStock-582280216.png

Chewable tablets as a dosage form are growing in popularity. Palatable chewable tablets offer convenience for customers, broaden the applicability of formulations to pediatric or geriatric markets, and increase patient compliance

Thumb_Excipients_RheologyModifier.jpg

Rheology modifier, dosage form, liquid dosage forms, semi-solid formulations, thickeners, topical applications, thickening agent, Dow, Dow Pharma Solutions, METHOCEL, WALOCEL

Thumb_Excipients_SolubilityEnhancement.jpg

Dow’s portfolio of solubility enhancing excipients for drug compounds with low aqueous solubility.

4.2.3_Thumb_tabelt_coating.jpg

Dow’s excipients for film tablet coatings are tough, printable, economical and highly consistent.

Thumb_Applications_TasteMasking.jpg

Dow’s excipients for taste masking applications in the oral drug delivery of tablets.

iStock-467924581.png

Topical formulations enable local delivery of a drug to a specific site of action without systemic exposure and may be creams, gels, or sprays.

Get Started

DuPont cares about your privacy. Your personal information (name, email, phone number and other contact data) will be stored in chosen customer systems primarily hosted in the United States. This information will be used by DuPont, its affiliates, partners, and selected third parties in other countries to provide you with the product or service information requested. To learn more, please visit www.privacy.dupont.com. By providing your personal information, you agree to the terms and conditions of this Privacy Statement.

 
 
 
/content/dupont/amer/us/en/nutrition-health/references/contact-us.html /content/dupont/amer/us/en/nutrition-health/references/corporate-contact-us.html /content/dupont/amer/us/en/nutrition-health/references/subscribe.html